Concord Drugs Ltd — Important, 20-01-2026: Company Update

The company has filed a compliance certificate from its Registrar and Share Transfer Agent, confirming the efficient management of shareholder records. This certificate verifies that all requests for dematerialization of shares were processed and physical certificates were extinguished within the specified timeframe. It also assures that there were no pending requests for rematerialization. This update highlights the company's robust operational compliance in handling investor securities, ensuring smooth and timely processing of share-related transactions, which is crucial for maintaining investor trust and market integrity.